Advanced search
Publication Cover
Current Medical Research and Opinion Volume 21, 2005 - Issue 11
Submit an article Journal homepage
77
Views
5
CrossRef citations to date
0
Altmetric
Original Article

A Markov modelled pharmacoeconomic analysis of bimatoprost 0.03% in the treatment of glaucoma as an alternative to filtration surgery in Italy

Torsten Lundgaard Christensen Muusmann Research & Consulting, Kolding, Denmark
,
Peter Bo Poulsen Muusmann Research & Consulting, Kolding, DenmarkCorrespondence[email protected]
,
Stefan Holmstrom Allergan France S.A.S., Mougins Cedex, France
,
John G. Walt Global Health Outcomes, Allergan, Irvine, USA
&
Michele Vetrugno Department of Ophthalmology, University of Bari, Italy
Pages 1837-1843 | Accepted 27 Sep 2005, Published online: 13 Oct 2005

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Glenis J Crane, Steven M Kymes, Janet E Hiller, Robert Casson & Jonathan D Karnon. (2013) Development and calibration of a constrained resource health outcomes simulation model of hospital-based glaucoma services. Health Systems 2:3, pages 181-197.
Read now

Articles from other publishers (4)

A.S. Neubauer, C. Hirneiß & A. Kampik. (2010) Modellierung in der „value-based medicine“Modeling in value-based medicine. Der Ophthalmologe 107:3, pages 228-234.
Crossref
W C Stewart, J A Stewart & M A Mychaskiw. (2007) Cost-effectiveness of latanoprost and timolol maleate for the treatment of glaucoma in Scandinavia and the United Kingdom, using a decision-analytic health economic model. Eye 23:1, pages 132-140.
Crossref
William C. Stewart, Jeanette A. Stewart, Qasiem J. Nassar & Marko A. Mychaskiw. (2008) Cost-effectiveness of Treating Ocular Hypertension. Ophthalmology 115:1, pages 94-98.
Crossref
Jan D. Hirsch, Candis Morello, Renu Singh & Shira L. Robbins. (2007) Pharmacoeconomics of New Medications for Common Chronic Ophthalmic Diseases. Survey of Ophthalmology 52:6, pages 618-633.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.